CCND2 and AL amyloidosis: ZKSCAN3 was also shown to interact with the cyclin D2 (CCND2) promoter and activate its expression in multiple myeloma, in which ZKSCAN3 is also highly expressed compared to normal samples (Figure 4) [127].